Wave Life Sciences (WVE) Cash from Operations Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 34.32% |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | -39.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.18% |
| Dec 31, 2025 | -0.33% |
| Sep 30, 2025 | -20.31% |
| Jun 30, 2025 | -16.87% |
| Mar 31, 2025 | -16.50% |
| Dec 31, 2024 | -83.77% |
| Sep 30, 2024 | -18.14% |
| Jun 30, 2024 | -42.96% |
| Mar 31, 2024 | 9.01% |
| Dec 31, 2023 | -1.90% |
| Sep 30, 2023 | -19.54% |
| Jun 30, 2023 | 0.78% |
| Mar 31, 2023 | 73.89% |
| Dec 31, 2022 | 18.26% |
| Sep 30, 2022 | 16.26% |
| Jun 30, 2022 | 4.34% |
| Mar 31, 2022 | 7.50% |
| Dec 31, 2021 | 40.16% |
| Sep 30, 2021 | 0.96% |
| Jun 30, 2021 | -28.70% |
| Mar 31, 2021 | -11.02% |
| Dec 31, 2020 | -11.35% |
| Sep 30, 2020 | 4.84% |
| Jun 30, 2020 | -23.83% |
| Mar 31, 2020 | -14.65% |
| Dec 31, 2019 | -66.17% |
| Sep 30, 2019 | -54.55% |
| Jun 30, 2019 | -342.14% |
| Mar 31, 2019 | -91.84% |
| Dec 31, 2018 | -70.10% |
| Sep 30, 2018 | -116.77% |
| Jun 30, 2018 | 276.31% |
| Mar 31, 2018 | -171.57% |
| Dec 31, 2017 | -164.33% |